Interim report, January - June 2007
Important events in the second quarter• ONCOlog enters into a partnership agreement with the Belgian company IBA• ONCOlog receives breakthrough order for SEK 9 million• SACS Medical is granted 510k clearance by the FDA• Pharmacolog i Uppsala AB is a new portfolio company• LinkMed invests SEK 20 million in AnaMar Medical and IMED• IMED strengthens management with new CEO and Chairman• AbSorber, Recopharma and NovaHep move into new joint premisesImportant events after the period-end• ONCOlog out-licences cobalt technology business concept for SEK 12 million• Due to a delay